<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36477191</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration.</ArticleTitle><Pagination><StartPage>1340</StartPage><MedlinePgn>1340</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1340</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-022-04295-8</ELocationID><Abstract><AbstractText>The human microbiota is believed to influence health. Microbiome dysbiosis may be linked to neurological conditions like Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. We report the ability of a probiotic bacterial strain in halting neurodegeneration phenotypes. We show that Lacticaseibacillus rhamnosus HA-114 is neuroprotective in C. elegans models of amyotrophic lateral sclerosis and Huntington's disease. Our results show that neuroprotection from L. rhamnosus HA-114 is unique from other L. rhamnosus strains and resides in its fatty acid content. Neuroprotection by L. rhamnosus HA-114 requires acdh-1/ACADSB, kat-1/ACAT1 and elo-6/ELOVL3/6, which are associated with fatty acid metabolism and mitochondrial &#x3b2;-oxidation. Our data suggest that disrupted lipid metabolism contributes to neurodegeneration and that dietary intervention with L. rhamnosus HA-114 restores lipid homeostasis and energy balance through mitochondrial &#x3b2;-oxidation. Our findings encourage the exploration of L. rhamnosus HA-114 derived interventions to modify the progression of neurodegenerative diseases.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Labarre</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guitard</LastName><ForeName>Ericka</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tossing</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forest</LastName><ForeName>Anik</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre de Recherche, Institut de Cardiologie de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bareke</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labrecque</LastName><ForeName>Marjorie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Biochimie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xe9;treault</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre de Recherche, Institut de Cardiologie de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Nutrition, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alex Parker</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3333-2445</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada. ja.parker@umontreal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC, Canada. ja.parker@umontreal.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052201" MajorTopicYN="Y">Lacticaseibacillus rhamnosus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093622" MajorTopicYN="N">Lacticaseibacillus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="Y">Huntington Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>8</Day><Hour>11</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36477191</ArticleId><ArticleId IdType="pmc">PMC9729297</ArticleId><ArticleId IdType="doi">10.1038/s42003-022-04295-8</ArticleId><ArticleId IdType="pii">10.1038/s42003-022-04295-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 2016;375:2369&#x2013;2379. doi: 10.1056/NEJMra1600266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Astafurov K, et al. Oral microbiome link to neurodegeneration in glaucoma. PLoS ONE. 2014;9:e104416. doi: 10.1371/journal.pone.0104416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104416</ArticleId><ArticleId IdType="pmc">PMC4152129</ArticleId><ArticleId IdType="pubmed">25180891</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RI, Walker DW. Role of gut microbiota in aging-related health decline: insights from invertebrate models. Cell. Mol. Life Sci. 2017;75:93&#x2013;101. doi: 10.1007/s00018-017-2671-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2671-1</ArticleId><ArticleId IdType="pmc">PMC5754256</ArticleId><ArticleId IdType="pubmed">29026921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Yi J, Zhang Y-G, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 2015;3:e12356. doi: 10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Dopkins N, Nagarkatti PS, Nagarkatti M. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology. 2018;154:178&#x2013;185. doi: 10.1111/imm.12903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12903</ArticleId><ArticleId IdType="pmc">PMC5980216</ArticleId><ArticleId IdType="pubmed">29392733</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt NM, et al. Gut microbiome alterations in Alzheimer&#x2019;s disease. Sci. Rep. 2017;7:595. doi: 10.1038/s41598-017-13601-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13601-y</ArticleId><ArticleId IdType="pmc">PMC5648830</ArticleId><ArticleId IdType="pubmed">29051531</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson&#x2019;s disease. World J. Gastroenterol. 2015;21:10609&#x2013;10620. doi: 10.3748/wjg.v21.i37.10609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v21.i37.10609</ArticleId><ArticleId IdType="pmc">PMC4588083</ArticleId><ArticleId IdType="pubmed">26457021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann. NY Acad. Sci. 2018;1420:5&#x2013;25. doi: 10.1111/nyas.13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13416</ArticleId><ArticleId IdType="pubmed">28768369</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. J. Neuroimmunol. 2019;328:98&#x2013;104. doi: 10.1016/j.jneuroim.2019.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2019.01.004</ArticleId><ArticleId IdType="pubmed">30658292</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari E, et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer&#x2019;s disease: a randomized, double-blind and controlled trial. Front. Aging Neurosci. 2016;8:256. doi: 10.3389/fnagi.2016.00256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00256</ArticleId><ArticleId IdType="pmc">PMC5105117</ArticleId><ArticleId IdType="pubmed">27891089</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding A, Gonder U, Robinson SJ, Crean S, Singhrao SK. Exploring the association between Alzheimer&#x2019;s disease, oral health, microbial endocrinology and nutrition. Front. Aging Neurosci. 2017;9:1335. doi: 10.3389/fnagi.2017.00398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00398</ArticleId><ArticleId IdType="pmc">PMC5717030</ArticleId><ArticleId IdType="pubmed">29249963</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-G, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin. Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>MacNeil LT, Watson E, Arda HE, Zhu LJ, Walhout AJM. Diet-induced developmental acceleration independent of TOR and insulin in C. elegans. Cell. 2013;153:240&#x2013;252. doi: 10.1016/j.cell.2013.02.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.02.049</ArticleId><ArticleId IdType="pmc">PMC3821073</ArticleId><ArticleId IdType="pubmed">23540701</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulenburg H, F&#xe9;lix M-A. The natural biotic environment of Caenorhabditis elegans. Genetics. 2017;206:55&#x2013;86. doi: 10.1534/genetics.116.195511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.116.195511</ArticleId><ArticleId IdType="pmc">PMC5419493</ArticleId><ArticleId IdType="pubmed">28476862</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson E, MacNeil LT, Arda HE, Zhu LJ, Walhout AJM. Integration of metabolic and gene regulatory networks modulates the C. elegans dietary response. Cell. 2013;153:253&#x2013;266. doi: 10.1016/j.cell.2013.02.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.02.050</ArticleId><ArticleId IdType="pmc">PMC3817025</ArticleId><ArticleId IdType="pubmed">23540702</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson E, et al. Interspecies systems biology uncovers metabolites affecting C. elegans gene expression and life history traits. Cell. 2014;156:759&#x2013;770. doi: 10.1016/j.cell.2014.01.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.01.047</ArticleId><ArticleId IdType="pmc">PMC4169190</ArticleId><ArticleId IdType="pubmed">24529378</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbaba TK, Green-Harrison L, Buret AG. Modeling host-microbiome interactions in Caenorhabditis elegans. J. Nematol. 2018;49:348&#x2013;356. doi: 10.21307/jofnem-2017-082.</Citation><ArticleIdList><ArticleId IdType="doi">10.21307/jofnem-2017-082</ArticleId><ArticleId IdType="pmc">PMC5770281</ArticleId><ArticleId IdType="pubmed">29353922</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapira M. Host&#x2013;microbiota interactions in Caenorhabditis elegans and their significance. Curr. Opin. Microbiol. 2017;38:142&#x2013;147. doi: 10.1016/j.mib.2017.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2017.05.012</ArticleId><ArticleId IdType="pubmed">28623729</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Parker JA. Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans. Front. Genet. 2014;5:85. doi: 10.3389/fgene.2014.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2014.00085</ArticleId><ArticleId IdType="pmc">PMC4029022</ArticleId><ArticleId IdType="pubmed">24860590</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe9;ri&#xe8;pe J, Fossouo L, Parker JA. Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons. Nat. Commun. 2015;6:7319. doi: 10.1038/ncomms8319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8319</ArticleId><ArticleId IdType="pubmed">26059317</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmeisser K, Parker JA. Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagy. PLoS Genet. 2018;14:e1007561. doi: 10.1371/journal.pgen.1007561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007561</ArticleId><ArticleId IdType="pmc">PMC6191153</ArticleId><ArticleId IdType="pubmed">30192747</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. Identification and characterization of the vesicular GABA transporter. Nature. 1997;389:870&#x2013;876. doi: 10.1038/39908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/39908</ArticleId><ArticleId IdType="pubmed">9349821</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A, et al. Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PLoS ONE. 2012;7:e31321. doi: 10.1371/journal.pone.0031321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031321</ArticleId><ArticleId IdType="pmc">PMC3283630</ArticleId><ArticleId IdType="pubmed">22363618</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneda T, et al. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J. Cell. Sci. 2004;117:4055&#x2013;4066. doi: 10.1242/jcs.01275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01275</ArticleId><ArticleId IdType="pubmed">15280428</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignull HR, Moore FE, Tang SJ, Morimoto RI. Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J. Neurosci. 2006;26:7597&#x2013;7606. doi: 10.1523/JNEUROSCI.0990-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0990-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674286</ArticleId><ArticleId IdType="pubmed">16855087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science. 2006;311:1471&#x2013;1474. doi: 10.1126/science.1124514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1124514</ArticleId><ArticleId IdType="pubmed">16469881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K, Dorman JB, Rodan A, Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science. 1997;278:1319&#x2013;1322. doi: 10.1126/science.278.5341.1319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.278.5341.1319</ArticleId><ArticleId IdType="pubmed">9360933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A-L, Murphy CT, Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science. 2003;300:1142&#x2013;1145. doi: 10.1126/science.1083701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083701</ArticleId><ArticleId IdType="pubmed">12750521</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227&#x2013;230. doi: 10.1038/35065638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35065638</ArticleId><ArticleId IdType="pubmed">11242085</ArticleId></ArticleIdList></Reference><Reference><Citation>Apfeld J, O&#x2019;Connor G, McDonagh T, DiStefano PS, Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 2004;18:3004&#x2013;3009. doi: 10.1101/gad.1255404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1255404</ArticleId><ArticleId IdType="pmc">PMC535911</ArticleId><ArticleId IdType="pubmed">15574588</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley JF, Brignull HR, Weyers JJ, Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA. 2002;99:10417&#x2013;10422. doi: 10.1073/pnas.152161099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.152161099</ArticleId><ArticleId IdType="pmc">PMC124929</ArticleId><ArticleId IdType="pubmed">12122205</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujol N, et al. Distinct innate immune responses to infection and wounding in the C. elegans epidermis. Curr. Biol. 2008;18:481&#x2013;489. doi: 10.1016/j.cub.2008.02.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2008.02.079</ArticleId><ArticleId IdType="pmc">PMC2394561</ArticleId><ArticleId IdType="pubmed">18394898</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes CM, Petrova K, Benedetti C, Yang Y, Ron D. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev. Cell. 2007;13:467&#x2013;480. doi: 10.1016/j.devcel.2007.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2007.07.016</ArticleId><ArticleId IdType="pubmed">17925224</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfon M, et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 2002;415:92&#x2013;96. doi: 10.1038/415092a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/415092a</ArticleId><ArticleId IdType="pubmed">11780124</ArticleId></ArticleIdList></Reference><Reference><Citation>Link CD, Cypser JR, Johnson CJ, Johnson TE. Direct observation of stress response in Caenorhabditis elegans using a reporter transgene. Cell Stress Chaperones. 1999;4:235&#x2013;242. doi: 10.1379/1466-1268(1999)004&lt;0235:DOOSRI&gt;2.3.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1379/1466-1268(1999)004&lt;0235:DOOSRI&gt;2.3.CO;2</ArticleId><ArticleId IdType="pmc">PMC312938</ArticleId><ArticleId IdType="pubmed">10590837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea SL, Wu D, Cypser JR, Vaupel JW, Johnson TE. A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans. Nat. Genet. 2005;37:894&#x2013;898. doi: 10.1038/ng1608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1608</ArticleId><ArticleId IdType="pmc">PMC1479894</ArticleId><ArticleId IdType="pubmed">16041374</ArticleId></ArticleIdList></Reference><Reference><Citation>Matey-Hernandez ML, et al. Genetic and microbiome influence on lipid metabolism and dyslipidemia. Physiol. Genomics. 2018;50:117&#x2013;126. doi: 10.1152/physiolgenomics.00053.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00053.2017</ArticleId><ArticleId IdType="pmc">PMC5867613</ArticleId><ArticleId IdType="pubmed">29341867</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev. Endocr. Metab. Disord. 2019;20:461&#x2013;472. doi: 10.1007/s11154-019-09512-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-019-09512-0</ArticleId><ArticleId IdType="pmc">PMC6938793</ArticleId><ArticleId IdType="pubmed">31707624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamim A, Mahmood T, Ahsan F, Kumar A, Bagga P. Lipids: an insight into the neurodegenerative disorders. Clin. Nutr. Exp. 2018;20:1&#x2013;19. doi: 10.1016/j.yclnex.2018.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yclnex.2018.05.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts JL, Ristow M. Lipid and carbohydrate metabolism in Caenorhabditis elegans. Genetics. 2017;207:413&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5629314</ArticleId><ArticleId IdType="pubmed">28978773</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak HY, Nelson LS, Basson M, Johnson CD, Ruvkun G. Polygenic control of Caenorhabditis elegans fat storage. Nat. Genet. 2006;38:363&#x2013;368. doi: 10.1038/ng1739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1739</ArticleId><ArticleId IdType="pubmed">16462744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kniazeva M, Crawford QT, Seiber M, Wang C-Y, Han M. Monomethyl branched-chain fatty acids play an essential role in Caenorhabditis elegans development. PLoS Biol. 2004;2:E257. doi: 10.1371/journal.pbio.0020257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0020257</ArticleId><ArticleId IdType="pmc">PMC514883</ArticleId><ArticleId IdType="pubmed">15340492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang L-X, et al. Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats. Int. J. Mol. Sci. 2014;15:15&#x2013;28. doi: 10.3390/ijms15010015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15010015</ArticleId><ArticleId IdType="pmc">PMC3907795</ArticleId><ArticleId IdType="pubmed">24451125</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugahara H, Yao R, Odamaki T, Xiao JZ. Differences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environment. Benef. Microbes. 2017;8:463&#x2013;472. doi: 10.3920/BM2016.0158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2016.0158</ArticleId><ArticleId IdType="pubmed">28441886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulcha JT, et al. A persistence detector for metabolic network rewiring in an animal. Cell Rep. 2019;26:460&#x2013;468.e4. doi: 10.1016/j.celrep.2018.12.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.064</ArticleId><ArticleId IdType="pmc">PMC6368391</ArticleId><ArticleId IdType="pubmed">30625328</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBlanc JG, et al. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb. Cell Fact. 2017;16:79&#x2013;10. doi: 10.1186/s12934-017-0691-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-017-0691-z</ArticleId><ArticleId IdType="pmc">PMC5423028</ArticleId><ArticleId IdType="pubmed">28482838</ArticleId></ArticleIdList></Reference><Reference><Citation>Giese GE, et al. Caenorhabditis elegans methionine/S-adenosylmethionine cycle activity is sensed and adjusted by a nuclear hormone receptor. Elife. 2020;9:71. doi: 10.7554/eLife.60259.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60259</ArticleId><ArticleId IdType="pmc">PMC7561351</ArticleId><ArticleId IdType="pubmed">33016879</ArticleId></ArticleIdList></Reference><Reference><Citation>Raud B, et al. Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab. 2018;28:504&#x2013;515.e7. doi: 10.1016/j.cmet.2018.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.06.002</ArticleId><ArticleId IdType="pmc">PMC6747686</ArticleId><ArticleId IdType="pubmed">30043753</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C-H, et al. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of &#x3b2;-oxidation. PLoS Biol. 2018;16:e2003782. doi: 10.1371/journal.pbio.2003782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2003782</ArticleId><ArticleId IdType="pmc">PMC5892939</ArticleId><ArticleId IdType="pubmed">29596410</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, et al. The nuclear receptor DAF-12 regulates nutrient metabolism and reproductive growth in nematodes. PLoS Genet. 2015;11:e1005027. doi: 10.1371/journal.pgen.1005027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005027</ArticleId><ArticleId IdType="pmc">PMC4361679</ArticleId><ArticleId IdType="pubmed">25774872</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir HJ, et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab. 2017;26:884&#x2013;896.e5. doi: 10.1016/j.cmet.2017.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.09.024</ArticleId><ArticleId IdType="pmc">PMC5718936</ArticleId><ArticleId IdType="pubmed">29107506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-E, et al. Lipid biosynthesis coordinates a mitochondrial-to-cytosolic stress response. Cell. 2016;166:1539&#x2013;1552.e16. doi: 10.1016/j.cell.2016.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.08.027</ArticleId><ArticleId IdType="pmc">PMC5922983</ArticleId><ArticleId IdType="pubmed">27610574</ArticleId></ArticleIdList></Reference><Reference><Citation>Glatz JFC, Luiken JJFP. From fat to FAT (CD36/SR-B2): understanding the regulation of cellular fatty acid uptake. Biochimie. 2017;136:21&#x2013;26. doi: 10.1016/j.biochi.2016.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2016.12.007</ArticleId><ArticleId IdType="pubmed">28013071</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell SE, et al. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J. Biol. Chem. 2004;279:36235&#x2013;36241. doi: 10.1074/jbc.M400566200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M400566200</ArticleId><ArticleId IdType="pubmed">15161924</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CM, Stahl A. SLC27 fatty acid transport proteins. Mol. Asp. Med. 2013;34:516&#x2013;528. doi: 10.1016/j.mam.2012.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2012.07.010</ArticleId><ArticleId IdType="pmc">PMC3602789</ArticleId><ArticleId IdType="pubmed">23506886</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MW, et al. Dysregulation of lipids in Alzheimer&#x2019;s disease and their role as potential biomarkers. Alzheimers Dement. 2017;13:810&#x2013;827. doi: 10.1016/j.jalz.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.01.008</ArticleId><ArticleId IdType="pubmed">28242299</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J, et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab. 2004;30:121&#x2013;138. doi: 10.1016/S1262-3636(07)70098-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1262-3636(07)70098-8</ArticleId><ArticleId IdType="pubmed">15223984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kage-Nakadai E, et al. Two very long chain fatty acid acyl-CoA synthetase genes, acs-20 and acs-22, have roles in the cuticle surface barrier in Caenorhabditis elegans. PLoS ONE. 2010;5:e8857. doi: 10.1371/journal.pone.0008857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008857</ArticleId><ArticleId IdType="pmc">PMC2810326</ArticleId><ArticleId IdType="pubmed">20111596</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, et al. Neuroprotective effects of oleic acid in rodent models of cerebral ischaemia. Sci. Rep. 2019;9:10732. doi: 10.1038/s41598-019-47057-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47057-z</ArticleId><ArticleId IdType="pmc">PMC6656890</ArticleId><ArticleId IdType="pubmed">31341184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AY, Lee MH, Lee S, Cho EJ. Neuroprotective effect of alpha-linolenic acid against A&#x3b2;-mediated inflammatory responses in C6 glial cell. J. Agric. Food Chem. 2018;66:4853&#x2013;4861. doi: 10.1021/acs.jafc.8b00836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.8b00836</ArticleId><ArticleId IdType="pubmed">29668263</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C, Prasad AA. Probiotics treatment improves hippocampal dependent cognition in a rodent model of Parkinson&#x2019;s disease. Microorganisms. 2020;8:1661. doi: 10.3390/microorganisms8111661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111661</ArticleId><ArticleId IdType="pmc">PMC7692862</ArticleId><ArticleId IdType="pubmed">33120961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishwanath VA. Fatty acid beta-oxidation disorders: a brief review. Ann. Neurosci. 2016;23:51&#x2013;55. doi: 10.1159/000443556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443556</ArticleId><ArticleId IdType="pmc">PMC4934411</ArticleId><ArticleId IdType="pubmed">27536022</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S-J, Zhang J, Choi AMK, Kim HP. Mitochondrial dysfunction induces formation of lipid droplets as a generalized response to stress. Oxid. Med. Cell Longev. 2013;2013:327167. doi: 10.1155/2013/327167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/327167</ArticleId><ArticleId IdType="pmc">PMC3794647</ArticleId><ArticleId IdType="pubmed">24175011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati S, et al. Bacillus subtilis delays neurodegeneration and behavioral impairment in the Alzheimer&#x2019;s disease model Caenorhabditis elegans. J. Alzheimers Dis. 2020;73:1035&#x2013;1052. doi: 10.3233/JAD-190837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190837</ArticleId><ArticleId IdType="pubmed">31884470</ArticleId></ArticleIdList></Reference><Reference><Citation>Goya ME, et al. Probiotic Bacillus subtilis protects against &#x3b1;-synuclein aggregation in C. elegans. Cell Rep. 2020;30:367&#x2013;380.e7. doi: 10.1016/j.celrep.2019.12.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.12.078</ArticleId><ArticleId IdType="pmc">PMC6963774</ArticleId><ArticleId IdType="pubmed">31940482</ArticleId></ArticleIdList></Reference><Reference><Citation>Urrutia A, et al. Bacterially produced metabolites protect C. elegans neurons from degeneration. PLoS Biol. 2020;18:e3000638. doi: 10.1371/journal.pbio.3000638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000638</ArticleId><ArticleId IdType="pmc">PMC7092960</ArticleId><ArticleId IdType="pubmed">32208418</ArticleId></ArticleIdList></Reference><Reference><Citation>Grompone G, et al. Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans. PLoS ONE. 2012;7:e52493. doi: 10.1371/journal.pone.0052493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052493</ArticleId><ArticleId IdType="pmc">PMC3530454</ArticleId><ArticleId IdType="pubmed">23300685</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P, Vieau D, Blum D, Peters&#xe9;n &#xc5;, Dupuis L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front. Mol. Neurosci. 2018;11:2. doi: 10.3389/fnmol.2018.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00002</ArticleId><ArticleId IdType="pmc">PMC5780436</ArticleId><ArticleId IdType="pubmed">29403354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332&#x2013;342. doi: 10.1016/S1474-4422(15)00380-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00380-4</ArticleId><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Khan R, Polymenidou M, Schulz PE. Disease-modifying effects of metabolic perturbations in ALS/FTLD. Mol. Neurodegener. 2018;13:63. doi: 10.1186/s13024-018-0294-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0294-0</ArticleId><ArticleId IdType="pmc">PMC6278047</ArticleId><ArticleId IdType="pubmed">30509290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nodera H, et al. Frequent hepatic steatosis in amyotrophic lateral sclerosis: Implication for systemic involvement. Neurol. Clin. Neurosci. 2015;3:58&#x2013;62. doi: 10.1111/ncn3.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.143</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, et al. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. J. Neurosci. 2020;40:9137&#x2013;9147. doi: 10.1523/JNEUROSCI.1388-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1388-20.2020</ArticleId><ArticleId IdType="pmc">PMC7673008</ArticleId><ArticleId IdType="pubmed">33051352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Yang EJ. Relationship between liver pathology and disease progression in a murine model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2018;18:200&#x2013;207. doi: 10.1159/000491392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000491392</ArticleId><ArticleId IdType="pubmed">30130789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D-G, et al. Non-alcoholic fatty liver disease induces signs of Alzheimer&#x2019;s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J. Neuroinflammation. 2016;13:1. doi: 10.1186/s12974-015-0467-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0467-5</ArticleId><ArticleId IdType="pmc">PMC4700622</ArticleId><ArticleId IdType="pubmed">26728181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta G, Qin H, Song J. Intrinsically unstructured domain 3 of hepatitis C virus NS5A forms a &#x2018;fuzzy complex&#x2019; with VAPB-MSP domain which carries ALS-causing mutations. PLoS ONE. 2012;7:e39261. doi: 10.1371/journal.pone.0039261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039261</ArticleId><ArticleId IdType="pmc">PMC3374797</ArticleId><ArticleId IdType="pubmed">22720086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolkipli Z, et al. Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks. Eur. J. Paediatr. Neurol. 2012;16:549&#x2013;553. doi: 10.1016/j.ejpn.2012.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2012.01.004</ArticleId><ArticleId IdType="pubmed">22264649</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash LA, Burns JK, Chardon JW, Kothary R, Parks RJ. Spinal muscular atrophy: more than a disease of motor neurons? Curr. Mol. Med. 2016;16:779&#x2013;792. doi: 10.2174/1566524016666161128113338.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524016666161128113338</ArticleId><ArticleId IdType="pubmed">27894243</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, et al. Untargeted metabolomics yields insight into ALS disease mechanisms. J. Neurol. Neurosurg. Psychiatr. 2020;91:1329&#x2013;1338. doi: 10.1136/jnnp-2020-323611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323611</ArticleId><ArticleId IdType="pmc">PMC7677469</ArticleId><ArticleId IdType="pubmed">32928939</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P, et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat. Med. 2021;27:1197&#x2013;1204. doi: 10.1038/s41591-021-01346-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01346-1</ArticleId><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang HJ, et al. Matrix-assisted laser desorption/ionization mass spectrometry imaging of phospholipid changes in a Drosophila model of early amyotrophic lateral sclerosis. J. Am. Soc. Mass Spectrom. 2021;32:2536&#x2013;2545. doi: 10.1021/jasms.1c00167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jasms.1c00167</ArticleId><ArticleId IdType="pubmed">34448582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Beltr&#xe1;n LC, et al. A transcriptomic meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of SOD1 mice. Int. J. Mol. Sci. 2021;22:9553. doi: 10.3390/ijms22179553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179553</ArticleId><ArticleId IdType="pmc">PMC8431303</ArticleId><ArticleId IdType="pubmed">34502460</ArticleId></ArticleIdList></Reference><Reference><Citation>Burg T, Rossaert E, Moisse M, Van Damme P, Van Den Bosch L. Histone deacetylase inhibition regulates lipid homeostasis in a mouse model of amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2021;22:11224. doi: 10.3390/ijms222011224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222011224</ArticleId><ArticleId IdType="pmc">PMC8541517</ArticleId><ArticleId IdType="pubmed">34681883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella R, et al. Perturbations of the proteome and of secreted metabolites in primary astrocytes from the hSOD1(G93A) ALS mouse model. Int. J. Mol. Sci. 2021;22:7028. doi: 10.3390/ijms22137028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137028</ArticleId><ArticleId IdType="pmc">PMC8268687</ArticleId><ArticleId IdType="pubmed">34209958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaert E, et al. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol. Commun. 2019;7:107&#x2013;119. doi: 10.1186/s40478-019-0750-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0750-2</ArticleId><ArticleId IdType="pmc">PMC6612190</ArticleId><ArticleId IdType="pubmed">31277703</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, et al. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:362&#x2013;370. doi: 10.3109/21678421.2014.908311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.908311</ArticleId><ArticleId IdType="pubmed">24984169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, et al. Biochemical alterations associated with ALS. Amyotroph. Lateral Scler. 2012;13:110&#x2013;118. doi: 10.3109/17482968.2011.619197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.619197</ArticleId><ArticleId IdType="pubmed">22117131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf P, et al. The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis. J. Clin. Neurosci. 2021;89:232&#x2013;236. doi: 10.1016/j.jocn.2021.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.05.017</ArticleId><ArticleId IdType="pubmed">34119273</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci. Rep. 2017;7:1004. doi: 10.1038/s41598-017-17389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17389-9</ArticleId><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kira Y, Nishikawa M, Ochi A, Sato E, Inoue M. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis. Brain Res. 2006;1070:206&#x2013;214. doi: 10.1016/j.brainres.2005.11.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2005.11.052</ArticleId><ArticleId IdType="pubmed">16412993</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14:397&#x2013;405. doi: 10.3109/21678421.2013.764568.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.764568</ArticleId><ArticleId IdType="pubmed">23421600</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, et al. Medium-chain fatty acids, beta-hydroxybutyric acid and genetic modulation of the carnitine shuttle are protective in a drosophila model of ALS based on TDP-43. Front. Mol. Neurosci. 2018;11:182. doi: 10.3389/fnmol.2018.00182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00182</ArticleId><ArticleId IdType="pmc">PMC5990617</ArticleId><ArticleId IdType="pubmed">29904341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl Acad. Sci. USA. 2008;105:4022&#x2013;4027. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan L, et al. Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature. 2017;543:443&#x2013;446. doi: 10.1038/nature21695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21695</ArticleId><ArticleId IdType="pmc">PMC5793917</ArticleId><ArticleId IdType="pubmed">28241148</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg MS, et al. Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS. Commun. Biol. 2021;4:509&#x2013;523. doi: 10.1038/s42003-021-02034-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02034-z</ArticleId><ArticleId IdType="pmc">PMC8087699</ArticleId><ArticleId IdType="pubmed">33931719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, et al. Triheptanoin protects motor neurons and delays the onset of motor symptoms in a mouse model of amyotrophic lateral sclerosis. PLoS ONE. 2016;11:e0161816. doi: 10.1371/journal.pone.0161816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161816</ArticleId><ArticleId IdType="pmc">PMC5001695</ArticleId><ArticleId IdType="pubmed">27564703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29. doi: 10.1186/1471-2202-7-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-7-29</ArticleId><ArticleId IdType="pmc">PMC1488864</ArticleId><ArticleId IdType="pubmed">16584562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ari C, et al. Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS ONE. 2014;9:e103526. doi: 10.1371/journal.pone.0103526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103526</ArticleId><ArticleId IdType="pmc">PMC4111621</ArticleId><ArticleId IdType="pubmed">25061944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE. 2012;7:e49191. doi: 10.1371/journal.pone.0049191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049191</ArticleId><ArticleId IdType="pmc">PMC3492315</ArticleId><ArticleId IdType="pubmed">23145119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, et al. A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun. Biol. 2020;3:526&#x2013;529. doi: 10.1038/s42003-020-01251-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01251-2</ArticleId><ArticleId IdType="pmc">PMC7511394</ArticleId><ArticleId IdType="pubmed">32968195</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A, et al. Genome-wide meta-analysis finds the ACSL5-ZDHHC6 locus is associated with ALS and links weight loss to the disease genetics. Cell Rep. 2020;33:108323. doi: 10.1016/j.celrep.2020.108323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108323</ArticleId><ArticleId IdType="pmc">PMC7610013</ArticleId><ArticleId IdType="pubmed">33113361</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann. Neurol. 1987;22:580&#x2013;586. doi: 10.1002/ana.410220504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410220504</ArticleId><ArticleId IdType="pubmed">3501273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatazawa J, Brooks RA, Dalakas MC, Mansi L, Di Chiro G. Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. J. Comput. Assist. Tomogr. 1988;12:630&#x2013;636. doi: 10.1097/00004728-198807000-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004728-198807000-00019</ArticleId><ArticleId IdType="pubmed">3260610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol. Scand. 1992;85:81&#x2013;89. doi: 10.1111/j.1600-0404.1992.tb04003.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1992.tb04003.x</ArticleId><ArticleId IdType="pubmed">1574993</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, et al. Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol. Dis. 2006;22:599&#x2013;610. doi: 10.1016/j.nbd.2006.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.01.001</ArticleId><ArticleId IdType="pubmed">16616851</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K, et al. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J. Cereb. Blood Flow Metab. 2012;32:456&#x2013;467. doi: 10.1038/jcbfm.2011.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.155</ArticleId><ArticleId IdType="pmc">PMC3293114</ArticleId><ArticleId IdType="pubmed">22068226</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J. Neurol. Sci. 1984;63:317&#x2013;324. doi: 10.1016/0022-510X(84)90154-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(84)90154-0</ArticleId><ArticleId IdType="pubmed">6374040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P-F, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Kamel F, Bellocco R, Ye W, Fang F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur. J. Neurol. 2015;22:1436&#x2013;1442. doi: 10.1111/ene.12632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12632</ArticleId><ArticleId IdType="pmc">PMC4506907</ArticleId><ArticleId IdType="pubmed">25600257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Brown JA, Schulz PE. Diabetes mellitus in amyotrophic lateral sclerosis: Dr. Jekyll or Mr. Hyde? Eur. J. Neurol. 2015;22:1419&#x2013;1420. doi: 10.1111/ene.12660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12660</ArticleId><ArticleId IdType="pubmed">25597340</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife. 2019;8:606. doi: 10.7554/eLife.45114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res. 2007;48:1571&#x2013;1580. doi: 10.1194/jlr.M700017-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M700017-JLR200</ArticleId><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin. J. Med. 2008;75:721&#x2013;728. doi: 10.3949/ccjm.75.10.721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.75.10.721</ArticleId><ArticleId IdType="pubmed">18939388</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, et al. 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS ONE. 2010;5:e13223. doi: 10.1371/journal.pone.0013223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013223</ArticleId><ArticleId IdType="pmc">PMC2951909</ArticleId><ArticleId IdType="pubmed">20949041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, et al. Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. Clin. Chim. Acta. 2010;411:563&#x2013;567. doi: 10.1016/j.cca.2010.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.01.016</ArticleId><ArticleId IdType="pubmed">20096678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80:829&#x2013;838. doi: 10.1212/WNL.0b013e3182840689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt F, Hussain G, Dupuis L, Loeffler J-P, Henriques A. A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front. Cell Neurosci. 2014;8:25. doi: 10.3389/fncel.2014.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00025</ArticleId><ArticleId IdType="pmc">PMC3929843</ArticleId><ArticleId IdType="pubmed">24600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiq MK, Lee E, Bradburn M, McDermott CJ, Shaw PJ. Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: insights from the olesoxime clinical trial. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:478&#x2013;484. doi: 10.3109/21678421.2015.1062517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1062517</ArticleId><ArticleId IdType="pubmed">26161993</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi, Y. et al. Frequent hepatic steatosis in ALS: implication for systemic involvement (P6.098). Neurology84, P6.098 (2015).</Citation></Reference><Reference><Citation>Hollinger SK, Okosun IS, Mitchell CS. Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom? Front. Neurol. 2016;7:47. doi: 10.3389/fneur.2016.00047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00047</ArticleId><ArticleId IdType="pmc">PMC4810157</ArticleId><ArticleId IdType="pubmed">27065942</ArticleId></ArticleIdList></Reference><Reference><Citation>Afifi AK, Aleu FP, Goodgold J, MacKay B. Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis. Neurology. 1966;16:475&#x2013;481. doi: 10.1212/WNL.16.5.475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.16.5.475</ArticleId><ArticleId IdType="pubmed">5949060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 1996;204:53&#x2013;56. doi: 10.1016/0304-3940(96)12314-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12314-4</ArticleId><ArticleId IdType="pubmed">8929976</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L, et al. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 1996;39:203&#x2013;216. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1998;156:65&#x2013;72. doi: 10.1016/S0022-510X(98)00008-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00008-2</ArticleId><ArticleId IdType="pubmed">9559989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J. 2003;17:2091&#x2013;2093. doi: 10.1096/fj.02-1182fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-1182fje</ArticleId><ArticleId IdType="pubmed">14500553</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, et al. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp. Neurol. 2006;198:25&#x2013;30. doi: 10.1016/j.expneurol.2005.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.07.020</ArticleId><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S, et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain. 2000;123:1339&#x2013;1348. doi: 10.1093/brain/123.7.1339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.7.1339</ArticleId><ArticleId IdType="pubmed">10869047</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasnianski A, et al. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain. 2005;128:1870&#x2013;1876. doi: 10.1093/brain/awh540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh540</ArticleId><ArticleId IdType="pubmed">15901649</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Song Y, Kincaid B, Bossy B, Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1&#x3b1;. Neurobiol. Dis. 2013;51:72&#x2013;81. doi: 10.1016/j.nbd.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Duffy LM, Shaw PJ, Grierson AJ. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2015;36:2893&#x2013;2903. doi: 10.1016/j.neurobiolaging.2015.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.07.013</ArticleId><ArticleId IdType="pubmed">26344876</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C, et al. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol. Neurodegener. 2017;12:76. doi: 10.1186/s13024-017-0217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, et al. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 2018;10:109. doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak J, et al. Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics. FASEB J. 2019;33:4388&#x2013;4403. doi: 10.1096/fj.201801843R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801843R</ArticleId><ArticleId IdType="pubmed">30550341</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiernagle, T. Maintenance of C. elegans. WormBook 1&#x2013;11 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781397</ArticleId><ArticleId IdType="pubmed">18050451</ArticleId></ArticleIdList></Reference><Reference><Citation>C. elegans Deletion Mutant Consortium. large-scale screening for targeted knockouts in the Caenorhabditis elegans genome. G3. 2012;2:1415&#x2013;1425. doi: 10.1534/g3.112.003830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.112.003830</ArticleId><ArticleId IdType="pmc">PMC3484672</ArticleId><ArticleId IdType="pubmed">23173093</ArticleId></ArticleIdList></Reference><Reference><Citation>Soukas AA, Kane EA, Carr CE, Melo JA, Ruvkun G. Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev. 2009;23:496&#x2013;511. doi: 10.1101/gad.1775409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1775409</ArticleId><ArticleId IdType="pmc">PMC2648650</ArticleId><ArticleId IdType="pubmed">19240135</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke EJ, Soukas AA, Carr CE, Ruvkun G. C. elegans major fats are stored in vesicles distinct from lysosome-related organelles. Cell Metab. 2009;10:430&#x2013;435. doi: 10.1016/j.cmet.2009.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2009.10.002</ArticleId><ArticleId IdType="pmc">PMC2921818</ArticleId><ArticleId IdType="pubmed">19883620</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114&#x2013;2120. doi: 10.1093/bioinformatics/btu170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu170</ArticleId><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:57. doi: 10.1186/1471-2105-12-323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-323</ArticleId><ArticleId IdType="pmc">PMC3163565</ArticleId><ArticleId IdType="pubmed">21816040</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:31. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25&#x2013;29. doi: 10.1038/75556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/75556</ArticleId><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330&#x2013;D338. doi: 10.1093/nar/gky1055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1055</ArticleId><ArticleId IdType="pmc">PMC6323945</ArticleId><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45:D183&#x2013;D189. doi: 10.1093/nar/gkw1138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1138</ArticleId><ArticleId IdType="pmc">PMC5210595</ArticleId><ArticleId IdType="pubmed">27899595</ArticleId></ArticleIdList></Reference><Reference><Citation>Forest A, et al. Comprehensive and reproducible untargeted lipidomic workflow using LC-QTOF validated for human plasma analysis. J. Proteome Res. 2018;17:3657&#x2013;3670. doi: 10.1021/acs.jproteome.8b00270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00270</ArticleId><ArticleId IdType="pmc">PMC6572761</ArticleId><ArticleId IdType="pubmed">30256116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>